 Shu-Yi Liao
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis | 5 | 2026 | 160 | 2.470 |
Why?
| | Genetic Predisposition to Disease | 4 | 2025 | 2363 | 1.150 |
Why?
| | HLA-DRB1 Chains | 2 | 2025 | 109 | 1.070 |
Why?
| | HLA-DP beta-Chains | 1 | 2025 | 87 | 0.890 |
Why?
| | Berylliosis | 1 | 2025 | 202 | 0.780 |
Why?
| | Genome-Wide Association Study | 3 | 2025 | 1406 | 0.760 |
Why?
| | Gene-Environment Interaction | 1 | 2023 | 180 | 0.720 |
Why?
| | Transcriptome | 2 | 2026 | 1045 | 0.660 |
Why?
| | Granuloma | 1 | 2021 | 96 | 0.660 |
Why?
| | Adenomyosis | 2 | 2017 | 6 | 0.640 |
Why?
| | Endometrium | 2 | 2017 | 61 | 0.620 |
Why?
| | Asthma | 2 | 2022 | 1767 | 0.610 |
Why?
| | Sarcoidosis, Pulmonary | 3 | 2026 | 95 | 0.610 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 264 | 0.600 |
Why?
| | beta 2-Microglobulin | 1 | 2018 | 47 | 0.580 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 173 | 0.540 |
Why?
| | HLA Antigens | 1 | 2018 | 225 | 0.520 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 478 | 0.520 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 202 | 0.510 |
Why?
| | Carcinoma, Renal Cell | 1 | 2018 | 234 | 0.480 |
Why?
| | Infertility, Female | 1 | 2017 | 112 | 0.470 |
Why?
| | Macrophages | 2 | 2026 | 1511 | 0.430 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 920 | 0.380 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 138 | 0.350 |
Why?
| | Alleles | 2 | 2025 | 879 | 0.340 |
Why?
| | Antibody Formation | 2 | 2022 | 294 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 3 | 2026 | 2730 | 0.310 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2637 | 0.290 |
Why?
| | Antibodies, Viral | 2 | 2022 | 672 | 0.270 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2025 | 2145 | 0.250 |
Why?
| | Embryo Implantation | 2 | 2017 | 30 | 0.250 |
Why?
| | Humans | 19 | 2026 | 144759 | 0.230 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2026 | 636 | 0.220 |
Why?
| | Beryllium | 1 | 2025 | 161 | 0.210 |
Why?
| | Lung | 3 | 2026 | 4109 | 0.210 |
Why?
| | Cell Communication | 1 | 2026 | 324 | 0.210 |
Why?
| | HLA-DR alpha-Chains | 1 | 2023 | 5 | 0.200 |
Why?
| | Biological Therapy | 1 | 2022 | 28 | 0.180 |
Why?
| | Genetic Association Studies | 1 | 2023 | 372 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 573 | 0.160 |
Why?
| | Middle Aged | 7 | 2026 | 35875 | 0.160 |
Why?
| | Genotype | 1 | 2025 | 1833 | 0.160 |
Why?
| | Female | 11 | 2026 | 78271 | 0.160 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 780 | 0.160 |
Why?
| | Stromal Cells | 2 | 2017 | 124 | 0.150 |
Why?
| | Adult | 7 | 2026 | 40449 | 0.150 |
Why?
| | Administration, Inhalation | 1 | 2020 | 574 | 0.150 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.140 |
Why?
| | Propensity Score | 1 | 2020 | 367 | 0.140 |
Why?
| | Genetic Variation | 1 | 2023 | 983 | 0.140 |
Why?
| | Odds Ratio | 1 | 2020 | 1075 | 0.130 |
Why?
| | Mice, SCID | 1 | 2018 | 369 | 0.130 |
Why?
| | Antigen Presentation | 1 | 2018 | 205 | 0.130 |
Why?
| | Receptors, OSM-LIF | 1 | 2016 | 1 | 0.130 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 463 | 0.130 |
Why?
| | Decidua | 1 | 2017 | 22 | 0.130 |
Why?
| | Cell Shape | 1 | 2017 | 57 | 0.130 |
Why?
| | Myometrium | 1 | 2017 | 38 | 0.120 |
Why?
| | Male | 9 | 2026 | 72315 | 0.120 |
Why?
| | Endometriosis | 1 | 2017 | 57 | 0.120 |
Why?
| | Logistic Models | 1 | 2020 | 2117 | 0.110 |
Why?
| | Viral Matrix Proteins | 1 | 2015 | 29 | 0.110 |
Why?
| | Phenotype | 1 | 2023 | 3162 | 0.110 |
Why?
| | Smoking | 1 | 2022 | 1472 | 0.110 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 207 | 0.110 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 219 | 0.110 |
Why?
| | Receptors, Antigen | 1 | 2014 | 14 | 0.110 |
Why?
| | Cohort Studies | 2 | 2026 | 5960 | 0.110 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2014 | 223 | 0.100 |
Why?
| | Herpesvirus 4, Human | 1 | 2015 | 176 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2015 | 286 | 0.100 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3540 | 0.100 |
Why?
| | Vaccination | 1 | 2022 | 1423 | 0.100 |
Why?
| | Cell Movement | 1 | 2017 | 965 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2014 | 467 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2018 | 2496 | 0.080 |
Why?
| | Aged | 2 | 2020 | 25913 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1129 | 0.070 |
Why?
| | Mutation | 1 | 2018 | 4089 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 10779 | 0.060 |
Why?
| | Radiography, Thoracic | 1 | 2026 | 171 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2026 | 521 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2026 | 547 | 0.050 |
Why?
| | Mice | 2 | 2018 | 18339 | 0.050 |
Why?
| | Signal Transduction | 1 | 2016 | 5226 | 0.050 |
Why?
| | Disease Progression | 2 | 2024 | 2847 | 0.050 |
Why?
| | Phosphorylation | 2 | 2017 | 1732 | 0.050 |
Why?
| | Fever | 1 | 2022 | 311 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2875 | 0.040 |
Why?
| | DNA Methylation | 1 | 2024 | 681 | 0.040 |
Why?
| | Animals | 2 | 2018 | 38058 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2017 | 4154 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 701 | 0.030 |
Why?
| | Stress Fibers | 1 | 2017 | 18 | 0.030 |
Why?
| | Dinucleoside Phosphates | 1 | 2016 | 31 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2017 | 72 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3604 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2832 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 173 | 0.030 |
Why?
| | Menstrual Cycle | 1 | 2017 | 140 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 851 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 476 | 0.030 |
Why?
| | K562 Cells | 1 | 2014 | 93 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 940 | 0.030 |
Why?
| | Actins | 1 | 2017 | 425 | 0.030 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2015 | 175 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2014 | 246 | 0.030 |
Why?
| | Antigens, CD19 | 1 | 2014 | 129 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1098 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2014 | 322 | 0.020 |
Why?
| | Lymphoma, B-Cell | 1 | 2014 | 132 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 499 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2015 | 699 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2015 | 1126 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 3121 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7173 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4557 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17066 | 0.010 |
Why?
| | Pregnancy | 1 | 2017 | 7190 | 0.010 |
Why?
|
|
Liao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|